Click the image above to download a PDF of the latest issue of Becker's ASC Review
Uncategorized
The House's version of the "Affordable Healthcare for America Act," HR 3962, which was released on Oct. 29, includes language against physician-ownership of hospitals, similar to the language included in draft versions of HR 3200, according to a statement by…
The U.S. Department of Health and Human Services issued an interim final rule with request for comments on stricter penalties issued for HIPAA violations under the Health Information Technology for Economic and Clinical Health, according to an HHS release.
House Democrats, following their Senate counterparts, have put a proposed Medicare pay fix for physicians into a separate bill from their health reform legislation, according to the Wall Street Journal Health Blog.
Here are eight facility expenses for surgery centers by the number of operating rooms in the center, according to VMG Health's 2009 Intellimarker.
Olympus has introduced VisiGlide, a new single use guidewire developed with advanced technology from Terumo Corporation to facilitate ERCP procedures performed by gastroenterologists, according to an Olympus news release.
Baptist Medical Center South in Jacksonville, Fla., opened its new ambulatory surgery center in the hospital's new 100,000 square-foot, five-story medical building, according to a report in Financial News & Daily Record.
NovaMed, an operator of ambulatory surgery centers in partnership with physicians, has announced its financial results for the third quarter ending Sept. 30. The company posted total net revenue growth of 8 percent to nearly $38.768 million, up from $36.05…
Raleigh, N.C.-based WakeMed, a 870-bed, non-profit hospital and healthcare system, is exploring a potential partnership with Surgical Care Affiliates, which manages ASCs throughout the country, according to a report in The News & Observer.
The U.S. Attorney for Massachusetts has indicted Stryker Biotech and four of its top managers, charging them with conducting fraudulent marketing for Stryker's OP-1 and Calstrux bone growth products, according to a release by the U.S. Attorney's Office.
